HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

2nd Edition of

World Orthopedics Conference

September 09-11, 2024 | Madrid, Spain

Ortho 2024

Sami Alsabri

Speaker at World Orthopedics Conference 2024 - Sami Alsabri
Universite de Montreal, Canada
Title : Role of DNA methylation on 15-lipoxygenase-1 gene expression in osteoarthritis

Abstract:

Objective and design. Osteoarthritis (OA) is the most prevalent type of arthritis and a major contributor to physical impairment with a significant financial impact. OA. Pain, stiffness, and a restricted range of motion are the primary signs and symptoms of OA. Genetics, age, obesity, joint damage, and knee malalignment are risk factors for OA. Numerous anti-inflammatory and immunomodulatory lipid mediators are produced by 15-lipoxygenase-1 (15-LOX-1), which has been shown to have protective effects against a number of inflammatory diseases, including OA. The purpose of this study was to assess the expression of 15-LOX-1 in the cartilage of OA patients and normal donors, as well as to ascertain whether DNA methylation controls this expression.

Methods. Cartilage samples were collected from both OA-affected at the time of total knee replacement surgery, and normal knee joints during autopsy. Real-time polymerase chain reaction (PCR) was used to assess the expression of 15-LOX-1. Using 5-Aza-2'-desoxycytidine (5-Aza-dC), a DNA methyltransferase inhibitor, the significance of DNA methylation in 15-LOX-1 expression was evaluated. Using a CpG-free luciferase vector, the impact of CpG methylation on the activity of the 15-LOX-1 promoter was assessed. Pyrosequencing was used to ascertain the 15-LOX-1 promoter's DNA methylation status.

Results. Compared to healthy cartilage, OA showed increased expression of 15-LOX-1. 15-LOX-1 mRNA levels were upregulated in chondrocytes treated with 5-Aza-dc, and 15-LOX-1 promoter activity was downregulated in vitro through methylation. The methylation status of the 15-LOX-1 gene promoter did not differ between cartilage from normal and OA cartilage.

Conclusion. In OA cartilage, there was an increased expression level of 15-LOX-1, which might be related to a healing process. The methylation status of 15-LOX-1's promoter was not linked to its upregulation in OA cartilage, indicating that alternative mechanisms may be at play.

Key words: 15-LOX-1, cartilage, osteoarthritis, chondrocyte, epigenetics, DNA methylation

Biography:

Sami G. Alsabri is a PhD student in the Pharmacology and Physiology Program at the University of Montreal. He obtained his master's degree from Wright State University, OH, US. His MSc. project was on the study of the potential therapeutic effect of extracellular microvesicles in wound healing. Currently he is carrying out his PhD studies under the supervision of Dr. H. Fahmi at Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM). His project focuses on the role of a key enzyme in prostglandin E2 metabolism, 15 Prostaglandin Dehydrogenase, in the pathogenesis of osteoarthritis.

Watsapp